XML 47 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Compensation Costs
Compensation cost charged against operations for the Plans and the 2017 MSPP described in "Note 10. Accumulated Other Comprehensive Income (Loss) and Shareholders’ Equity" in the Notes to Consolidated Financial Statements was as follows:
 202220212020
Compensation cost$9.0 $12.9 $7.8 
The total income tax benefit recognized in the Consolidated Statements of Comprehensive Income for share-based compensation arrangements was as follows:
 202220212020
Income tax benefit$2.0 $3.1 $1.9 
The following table details deferred compensation, which is a combination of cash and stock, and the affected line item in the Consolidated Balance Sheets where deferred compensation is presented:
December 31, 2022January 1, 2022
Current maturities of other long-term obligations$0.5 $1.5 
Other long-term liabilities6.6 9.0 
Total deferred compensation$7.0 $10.5 
Total fair-market value of deferred compensation$4.7 $8.1 
Schedule of Share-based Compensation, Restricted Stock Units Activity
The following table summarizes the changes in RSUs (shares in thousands, per share amounts in dollars):
 Number of SharesWeighted-Average Grant Date Fair Value
Nonvested as of December 28, 201922 $38.41 
Granted174 36.78 
Vested(7)40.77 
Forfeited(6)37.50 
Nonvested as of January 2, 2021182 $36.80 
Granted430 37.02 
Vested(63)37.09 
Forfeited(5)32.90 
Nonvested as of January 1, 2022545 $36.98 
Granted164 43.05 
Vested(141)36.99 
Forfeited(32)37.75 
Nonvested as of December 31, 2022535 $38.79 
The total value of shares vested was as follows:
202220212020
Value of shares vested$5.2 $2.3 $0.3 
Share-based Payment Arrangement, Performance Shares, Activity
The following table summarizes the changes in PSUs (shares in thousands, per share amounts in dollars):
 Number of SharesWeighted-Average Grant Date Fair Value
Nonvested as of December 28, 2019— $— 
Granted157 37.64 
Forfeited(9)38.08 
Nonvested as of January 2, 2021148 $37.62 
Granted164 36.99 
Forfeited(2)37.61 
Nonvested as of January 1, 2022309 $37.29 
Granted143 43.67 
Forfeited(24)39.60 
Nonvested as of December 31, 2022428 $39.29 
Schedule of Valuation Assumptions Stock-based compensation expense related to stock options was estimated on the date of grant using the Black-Scholes option-pricing model with various assumptions. Expected volatilities were based on historical volatility as the Corporation does not expect that future volatility over the expected term of the options is likely to differ from the past. The Corporation used a calculation method based on the historical daily frequency for a period of time equal to the expected term. The Corporation used the current dividend yield as there are no plans to substantially increase or decrease its dividends. The Corporation used historical exercise experience to determine the expected term. The risk-free interest rate was selected based on yields from treasury securities as published by the Federal Reserve equal to the expected term of the options. The amount of stock-based compensation expense recognized during a period is also based on the portion of the stock options that are ultimately expected to vest. The Corporation estimates pre-vesting forfeitures at the time of grant by analyzing historical data and revises those estimates in subsequent periods if actual forfeitures differ from those estimates.
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes the changes in outstanding stock options (shares in thousands, per share amounts in dollars):
 Number of SharesWeighted Average Exercise Price
Outstanding as of December 28, 20193,223 $39.24 
Exercised(189)29.24 
Forfeited or Expired(28)42.38 
Outstanding as of January 2, 20213,006 $39.84 
Exercised(815)35.04 
Forfeited or Expired(1)39.77 
Outstanding as of January 1, 20222,191 $41.62 
Exercised(64)33.35 
Forfeited or Expired(8)42.65 
Outstanding as of December 31, 20222,119 $41.86 
Schedule of Nonvested Restricted Stock Units Activity
A summary of the Corporation’s non-vested stock options and changes during the year are presented below (shares in thousands, per share amounts in dollars):
Number of SharesWeighted Average Grant-Date Fair Value
Nonvested as of January 1, 2022956 $9.79 
Vested(485)9.71 
Forfeited(3)9.88 
Nonvested as of December 31, 2022469 $9.87 
Stock Option Vested or Expected to Vest and are Exercisable
Information about stock options expected to vest or currently exercisable is as follows (shares in thousands, per share amounts in dollars):
December 31, 2022
Number of SharesWeighted-Average Exercise PriceWeighted-Average Remaining Exercisable Period
(years)
Aggregate Intrinsic Value
Expected to vest466 $39.74 6.1$0.0 
Exercisable1,650 $42.46 3.8$0.0 
Schedule of Share-based Compensation Arrangement Other Information
Other information for the last three years is as follows:
202220212020
Total fair value of options vested$4.7 $3.3 $3.6 
Total intrinsic value of options exercised$0.5 $5.4 $1.5 
Cash received from exercise of stock options$2.1 $28.5 $5.5 
Tax benefit realized from exercise of stock options$0.1 $1.0 $0.4